Cafepharma Today

March 5 2025 - Jazz hands over $935M to buy Chimerix for near-approval cancer drug
Jazz hands over $935M to buy Chimerix for near-approval cancer drug
Kenvue settles proxy fight with activist Starboard, appoints three directors
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
DOGE claims $30M savings from canceling 30 FDA leases
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

PDL BioPharma's Partnership Makes Sense
Motley Fool
Thursday, August 21, 2008 - 5:54pm
tags:
Johnson & Johnson Gets Rejected
Motley Fool
Thursday, August 21, 2008 - 5:50pm
tags:
Congressmen demand Merck, Schering-Plough supply info on possible Vytorin cancer risk
Yahoo/AP
Thursday, August 21, 2008 - 5:34pm
tags:
A Gardasil Gotcha
Motley Fool
Thursday, August 21, 2008 - 5:22pm
tags:
For Abbott, Diversity Remains Paramount
Yahoo/TheStreet.com
Thursday, August 21, 2008 - 5:18pm
tags:
Abbott to cut 1,000 jobs from diagnostic unit
Yahoo/AP
Thursday, August 21, 2008 - 5:14pm
tags:
Genzyme, PTC Therapeutics Cystic Fibrosis Drug Relieves Symptom
Bloomberg
Thursday, August 21, 2008 - 12:07pm
tags:
Bristol-Myers Ponies Up for Elotuzumab
Seeking Alpha
Thursday, August 21, 2008 - 12:06pm
tags:
Why I'm Buying Amylin Now
Seeking Alpha
Thursday, August 21, 2008 - 12:05pm
tags:
GlaxoSmithKline to Disclose Grants to Hospitals, Patient Groups
WSJ Online
Thursday, August 21, 2008 - 12:04pm
tags:
Lilly releases more favorable study results for cardio drug prasugrel, which awaits FDA OK
Yahoo/AP
Thursday, August 21, 2008 - 12:03pm
tags:
Abbott streamlining plan to save more than $150 mln a year
Marketwatch
Thursday, August 21, 2008 - 12:02pm
tags:
Alpharma Hurt by Medco as Insurers Balk at Pain Patch
Bloomberg
Thursday, August 21, 2008 - 12:00pm
tags:
P&G to License Noven's Patch for Women's Sex Drive
Bloomberg
Thursday, August 21, 2008 - 11:59am
tags:
Merck Cancer Shot May Not Be Economical for All Women
Bloomberg
Thursday, August 21, 2008 - 11:58am
tags:
Eli Lilly reports statistically superior results from Phase III head-to-head TRITON-TIMI 38 study - Quick Facts
RTT News
Thursday, August 21, 2008 - 11:56am
tags:
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Yahoo
Thursday, August 21, 2008 - 11:55am
tags:
FDA asks Johnson & Johnson for more information on Doribax
Marketwatch
Thursday, August 21, 2008 - 9:59am
tags:
Regeneron reports encouraging data from Phase II AMD trial
Pharmaceutical Business Review
Thursday, August 21, 2008 - 9:54am
tags:
AstraZeneca can claim compensation over copycat Prilosec
Pharma Times, UK
Thursday, August 21, 2008 - 9:52am
tags:

Pages

Latest CP Wire Articles

FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Latest Pharmagather Articles

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws
Drug Channels
The Continuing Crisis, Part VI: Rare Diseases at the FDA and More
In the Pipeline
PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)
Drug Channels
Progress on RNA-Based Cancer Vaccines
In the Pipeline
Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
The Thiazide Target, At Last
In the Pipeline
Drug Channels News Roundup, February 2025: Part D vs. Pharmacies, Accumulator Madness, Wholesaler Vertical Integration, IRA vs. MDs, and a 340B Cartoon
Drug Channels
Neurodegeneration Might Come Down to RNA
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information